MENU
AQST
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Aquestive Therapeutics (AQST) Ownership - Who owns Aquestive Therapeutics?

Profile

Industry
Pharmaceuticals Major
Address
30 Technology Drive
Phone
+1 908 941-1900
Employees
135
Web
https://www.aquestive.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
383.26M
P/E Ratio
N/A
Total Cash
23.87M
Projected Growth
N/A
Total Debt
33.32M
Revenue
50.58M
Risk (Beta)
1.72
Dividend Yield
N/A
Total Cash/Share
0.27
Total Debt/Equity
N/A
Revenue/Share
0.83 USD as % of share price

Fundamentals

AQST
Capitalization
383M
P/E Ratio
N/A
Risk (Beta)
1.72
Dividend Yield
N/A
Total Cash
23.9M
Total Cash/Share
0.27
Total Debt
33.3M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.83%
Revenue
50.6M
ROE
N/A
Book Value
-106.49M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-0.13
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
69K
Current Ratio
2.24
Current Revenue Per Employee
97822.22
Dividends Per Share - Security
N/A
EBITDA
1.18M
Float
N/A
Float - Current
N/A
Gross Income Margin
64.57
Revenue To Assets
-13.75
Shares Held By Institutions
57.4M
Shares Outstanding - Current
90M
Total Liabilities
164M
Total Volume MTD
N/A
Value
N/A
Gain YTD
90.594
View a ticker or compare two or three
AQST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer thin film pharmaceutical and over the counter drug products

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
30 Technology Drive
Phone
+1 908 941-1900
Employees
135
Web
https://www.aquestive.com